Deepflare

DeepSeq.AI

DeepSeq.AI develops an artificial intelligence platform for protein drug discovery and biologics design for pharmaceutical and biotechnology companies.

Sift Bio

The company develops a peptide immunotherapy platform that uses artificial intelligence to identify microbial analogs for treating solid tumours in cancer patients.

Alp Bio

This company develops a hybrid platform combining human immune organoids and artificial intelligence to assess immunogenicity risks for biotechnology and pharmaceutical drug developers.

Deep Origin

This company provides a computational drug discovery platform for biopharmaceutical researchers to simulate molecular properties and accelerate therapeutic development.

Deepcure

This company develops small molecule therapies for pharmaceutical organisations to treat inflammatory and autoimmune diseases using artificial intelligence and automated discovery tools.

Deep MedChem

This company develops artificial intelligence software for virtual screening and molecular discovery for pharmaceutical, biotechnology and academic drug discovery teams.

Computational drug discovery platform

This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.

DeepMirror

This company develops an artificial intelligence platform for medicinal chemists at biotechnology and pharmaceutical firms to design and optimise drug molecules.